The Effect of Epigenetic Reprogramming Using MI192 HDAC Inhibitor on Enhancing the Osteogenesis of Human Adipose-Derived Stem Cells In Vitro

The authors examined the effect of a novel HDAC2&3-selective inhibitor, MI192, on hADSCs epigenetic reprogramming for regulating its osteogenic potential in vitro.